Dose conversion to IPX066 in advanced Parkinson's disease patients treated with carbidopa-levodopa-entacapone

被引：0
|
作者：
Hsu, A.
Khanna, S.
Kell, S.
Espay, A.
Gil, R.
Singer, C.
Gupta, S.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
416
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [1] Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients
    Stocchi, Fabrizio
    Hsu, Ann
    Khanna, Santa
    Ellenbogen, Aaron
    Mahler, Andreas
    Liang, Grace
    Dillmann, Ulrich
    Rubens, Robert
    Kell, Sherron
    Gupta, Suneel
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (12) : 1335 - 1340
  • [2] Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson's disease patients: Dosing patterns
    Morgan, J.
    Stacy, M.
    Rubens, R.
    Khanna, S.
    Gupta, S.
    MOVEMENT DISORDERS, 2016, 31 : S659 - S659
  • [3] Conversion of advanced Parkinson's disease patients to IPX066, modified-release levodopa-carbidopa (NUMIENT™), from other levodopa-carbidopa formulations
    Gupta, S.
    Rubens, R.
    Rustay, N.
    Khanna, S.
    Kell, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 526 - 526
  • [4] Comparison of IPX066, a Carbidopa-Levodopa Extended Release Formulation with CD-LD IR plus Entacapone in Patients with Advanced Parkinson's Disease
    Stocchi, Fabrizio
    Hsu, Ann
    Khanna, Sarita
    Ellenbogen, Aaron
    Mahler, Andreas
    Liang, Grace
    Dillmann, U.
    Rubens, Robert
    Kell, Sherron
    Gupta, Suneel
    ANNALS OF NEUROLOGY, 2013, 74 : S42 - S42
  • [5] Efficacy of IPX066, extended-release levodopa-carbidopa in patients with advanced Parkinson's disease: Responder analyses
    Gupta, Suneel
    Khanna, Sarita
    Rustay, Nathan
    Rubens, Robert
    Kell, Sherron
    MOVEMENT DISORDERS, 2017, 32 : S36 - S36
  • [6] Characteristics of Advanced Parkinson's Disease Patients Who Discontinued During Conversion to IPX066, Extended-Release Carbidopa-Levodopa
    Kreitzman, David
    Dhall, Rohit
    Kell, Sherron
    Khanna, Sarita
    Gupta, Suneel
    NEUROLOGY, 2016, 86
  • [7] Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
    Pahwa, Rajesh
    Lyons, Kelly E.
    Hauser, Robert A.
    Fahn, Stanley
    Jankovic, Joseph
    Pourcher, Emmanuelle
    Hsu, Ann
    O'Connell, Martin
    Kell, Sherron
    Gupta, Suneel
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (02) : 142 - 148
  • [8] Comparison of single-dose motor effects of IPX066 to immediate-release carbidopa-levodopa plus entacapone (CLE) in advanced Parkinson's disease (PD) patients
    Ellenbogen, A.
    Stocchi, F.
    Duker, A. P.
    Hsu, A.
    Khanna, S.
    Modi, N.
    Rubens, R.
    Gupta, S.
    MOVEMENT DISORDERS, 2012, 27 : S115 - S116
  • [9] Dosing Patterns During Conversion to IPX066, Extended-Release Carbidopa-Levodopa, from Other Carbidopa-Levodopa Formulations in Advanced Parkinson's Disease Patients
    Morgan, John
    Stacy, Mark
    Rubens, Robert
    Khanna, Sarita
    Gupta, Suneel
    NEUROLOGY, 2016, 86
  • [10] Efficacy of IPX066, an extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease patients with troublesome dyskinesia
    Dhall, R.
    Struck, L.
    Rubens, R.
    Shah, V.
    Gupta, S.
    MOVEMENT DISORDERS, 2015, 30 : S79 - S80
12345